Navigation Links
Unigene's Oral PTH Phase 2 Proof-of-Concept Data to be Presented at Upcoming Scientific Conferences
Date:6/28/2012

BOONTON, N.J., June 28, 2012 /PRNewswire/ -- Unigene Laboratories, Inc. (OTCBB: UGNE), a leader in the design, delivery, manufacture and development of peptide-based therapeutics, today announced that data from the Company's oral parathyroid hormone (PTH) analog Phase 2 proof-of-concept trial results will be part of two presentations by Dr. Lorraine Fitzpatrick, Medicine Development Leader for GlaxoSmithKline (GSK), at prestigious scientific conferences. 

5th International Workshop on Advances in the Molecular Pharmacology and Therapeutics of Bone Disease

"(Mis)Adventures In Drug Discovery"

  • Date & Time: Thursday, June 28, 2012 at 11:30 a.m. GMT
  • Location:  St. Catherine's College, Oxford, UK
  • Focus: Examination of PTH secretory dynamics via the comparison of PK data from ronacaleret, oral PTH, and PTH 1-34 and 1-84 

GIOSEG 5th Meeting Skeletal Endocrinology

SESSION 4 - Anabolic Therapies for Osteoporosis – "New PTHs: Modalities, Duration, Combinations"

  • Date & Time: Friday, September 21, 2012 from 2:30 - 4:00 p.m. BST
  • Location: University of Brescia, Main Hall School of Medicine, Brescia, Italy
  • Focus: Examination of PTH secretory dynamics via the comparison of PK data from ronacaleret, oral PTH, and PTH 1-34 and 1-84

"We are extremely pleased Dr. Fitzpatrick has chosen to present the data from our oral PTH Phase 2 proof-of-concept trial at two highly prestigious scientific conferences," stated Nozer Mehta, Ph.D., Vice President of Research and Development for Unigene.  "Both presentations will serve to highlight data that strongly validate Unigene's proprietary Peptelligence™ technology and, importantly, that the oral delivery of PTH is technically feasible."

The Phase 2 proof-of-concept oral PTH study was conducted by Unigene
'/>"/>

SOURCE Unigene Laboratories, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Argos Therapeutics Secures $25 million Series D Financing to Commence Phase 3 ADAPT Study in Patients with Metastatic Renal Cell Carcinoma (mRCC) in Mid-2012
2. Anthera Announces the Completion of Patient Dosing in Phase 2b PEARL-SC Study
3. Omthera Pharmaceuticals Announces Positive Top-Line Results from Phase 3 EVOLVE Study
4. Retrospective Study Suggests that Stereotactic Ablative Radiotherapy (SABR) Can be a Viable Option for Treating Early-Stage Lung Cancer in Operable as well as Inoperable Patients; Phase III Randomized Trial Now Under Way
5. Ultragenyx Announces Phase 1 Results of UX001 in Hereditary Inclusion Body Myopathy (HIBM), a Rare Neuromuscular Disease
6. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
7. Isis Initiates Phase 2 Study of ISIS-APOCIIIRx in Patients with Hypertriglyceridemia
8. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
9. Results Reported for Phase Ib Open-Label Clinical Trial for the Treatment of Depression Using External Trigeminal Nerve Stimulation (eTNS™) - The USB Port to the Brain™
10. Pearl Therapeutics Phase 2b Twice-Daily Dosing Data Suggest Morning and Evening Benefit of PT003 in Patients with COPD
11. Adamas Pharmaceuticals Announces Successful End-of-Phase 2 Meeting with FDA for Arimenda™
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/25/2014)... CHAPEL HILL, N.C. , July 25, 2014 /PRNewswire/ ... of challenges, including understanding new advancements in technology and ... top of this, libraries in the pharmaceutical and medical ... the value of the information and services they provide. ... firm, Best Practices, LLC there are many forces of ...
(Date:7/25/2014)... , July 25, 2014  In today,s marketplace, ... costly and challenging - as is managing a portfolio ... Is it possible - or even preferable - ... so, where can you combine resources and activities, and ... These are just a few of the ...
(Date:7/25/2014)... "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides ... market. The report provides value, in millions of US ... dollars) within market segments: Photo - ... , Capsule Endoscopy Data Recorders , Capsule Endoscopy ... shares and distribution shares data for each of these ...
Breaking Medicine Technology:Forces of Change Reshaping Corporate Libraries & Information Services 2Using Promotional Efficiency to Support Multiple Products and Indications in the Pharmaceutical Marketplace 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5
... the nation seeks to expand health care coverage ... from Harvard University, Brigham and Women,s Hospital and ... that preventative health care may be significantly less ... of cost-effective generic medications for the treatment and ...
... July 7, 2011 ,   ... Yttrium-90 Resin Microspheres (ENRY),analysis of the long-term outcomes related ... with inoperable,primary liver tumours were published on-line today in, ... the Study of Liver,Diseases. [ 1 ] ...
Cached Medicine Technology:CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 2CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 3CVS Caremark, Harvard and Brigham and Women's Research Shows Generic Medications are Changing the Economics of Treating Chronically Ill Patients 4Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 2Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 3Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 4Largest Multi-Centre Evaluation of Radioembolization Using Sir-Spheres for Patients With Inoperable Primary Liver Cancer Published in Hepatology 5
(Date:7/25/2014)... AttorneyOne.com, a recognized authority on law, update ... FDA on Ibuprofen and Oxcarbazepine Tablets . , ... Ibuprofen and one lot of Oxcarbazepine Tablets, by American Health ... Oxcarbazepine is used for the treatment of certain types of ... for the recall is that Lot #142588, Expiration Date, 01/2016 ...
(Date:7/25/2014)... A new study of participants in the National Lung ... in Cancer , found evidence that men and women ... abnormal finding on a lung cancer screening test did not ... those who were screened and found to be cancer-free. ... “We expected that participants with an abnormal finding would be ...
(Date:7/25/2014)... TX (PRWEB) July 25, 2014 ... the current state of the Galactooligosaccharides (GOS) ... a basic overview of the industry, including definitions, ... and Chinese domestic market analysis are provided with ... landscape of the market. A comparison between the ...
(Date:7/25/2014)... 2014 (HealthDay News) -- Shift workers, especially men, may be ... not on such schedules, a new study suggests. Also ... a set schedule, with shifts moving around at various times ... surprising," said one expert, Dr. Alan Manevitz, a clinical psychiatrist ... have long known that working shifts disrupts many key body ...
(Date:7/25/2014)... sent patients to designated cardiac receiving centers dramatically increased ... in Arizona, according to a study published online yesterday ... , "We knew lives would be saved if the ... arrest care and we were able to get cardiac ... done for Level 1 trauma patients," said lead study ...
Breaking Medicine News(10 mins):Health News:Ibuprofen and Oxcarbazepine Tablets Recalled: AttorneyOne Monitors and Keep Consumers Informed 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 2Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 3Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 4Health News:Full Explanation Reduces Seniors’ Worries about Lung Cancer Screening 5Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 2Health News:GOS Market (Galacto-oligosaccharides) Development in Global & China Regions Now Available at DeepResearchReports.com 3Health News:Study Links Shift Work to Risk for Type 2 Diabetes 2Health News:Study Links Shift Work to Risk for Type 2 Diabetes 3Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 2Health News:New EMS system in Arizona dramatically improves survival from cardiac arrest 3
... News) -- Scientists believe they,ve discovered how HIV triggers the ... in turn leads to AIDS. It was believed that ... not actually infected, a situation labeled "bystander cell killing." ... "bystander" cells die because of a failed or abortive HIV ...
... of your love for your mate as the noble emotion ... brain are taking a decidedly more pragmatic approach to the ... cichlid fish, the scientists discovered that when a female shows ... losing a fight with another male, her feelings toward him ...
... Nov. 24 (HealthDay News) -- If you are one of ... gatherings, a few simple steps can help reduce your stress ... Decker School of Nursing at Binghamton University, State University of ... perishable items well ahead of time and have a list ...
... By Jenifer Goodwin HealthDay Reporter , TUESDAY, ... good predictor of academic performance, but not necessarily in ... the IQs and reading, spelling and math abilities of ... children,s social functioning through parental and teacher reports at ...
... HealthDay Reporter , TUESDAY, Nov. 23 (HealthDay News) -- With ... many Americans will soon be subjected to radiation-emitting body scanners ... concerns and complaints in recent weeks over body scanners, most ... low to pose any serious health threat. Peter Rez, ...
... 2010) - Even though most people are aware that good ... mother and child, misunderstandings about the safety of dental care ... dentist. The fact is that dentists can create a treatment ... adverse effects of oral disease during pregnancy. During the ...
Cached Medicine News:Health News:Scientists May Have Solved an HIV Mystery 2Health News:Female fish -- and humans? -- lose interest when their male loses a slugfest 2Health News:Female fish -- and humans? -- lose interest when their male loses a slugfest 3Health News:Female fish -- and humans? -- lose interest when their male loses a slugfest 4Health News:For Autistic Kids, IQ May Not Predict School Achievement 2Health News:For Autistic Kids, IQ May Not Predict School Achievement 3Health News:Airport Body Scanners Safe, Experts Say 2Health News:Airport Body Scanners Safe, Experts Say 3Health News:Expecting? Don't neglect your teeth 2
... real-time PCR detection system offers an affordable ... fluorescent dyes such as FAM and SYBR ... the iCycler thermal cycler, offering superior features ... performance. The MyiQ real-time PCR detection system ...
... is a rapid, real-time thermal cycler used ... By automating much of the testing process, ... it is the fastest, easiest to use, ... market. The SmartCycler delivers highly accurate and ...
Inquire...
Chemically Resistant Sealing Mat for 384ch, Square Well Available Sterile...
Medicine Products: